NO862690D0 - Monoklonale antistoffer og antigener for humane ikke-liten-celle lungekarcinomer (nsclc). - Google Patents
Monoklonale antistoffer og antigener for humane ikke-liten-celle lungekarcinomer (nsclc).Info
- Publication number
- NO862690D0 NO862690D0 NO862690A NO862690A NO862690D0 NO 862690 D0 NO862690 D0 NO 862690D0 NO 862690 A NO862690 A NO 862690A NO 862690 A NO862690 A NO 862690A NO 862690 D0 NO862690 D0 NO 862690D0
- Authority
- NO
- Norway
- Prior art keywords
- residues
- lungcarcinomes
- nsclc
- antigens
- cell
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 208000000649 small cell carcinoma Diseases 0.000 title 1
- 125000003563 glycoside group Chemical group 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 125000005629 sialic acid group Chemical group 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3023—Lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
- Y10S530/864—Monoclonal
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66752184A | 1984-11-02 | 1984-11-02 | |
| US78517785A | 1985-10-07 | 1985-10-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO862690D0 true NO862690D0 (no) | 1986-07-02 |
Family
ID=27099700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO862690A NO862690D0 (no) | 1984-11-02 | 1986-07-02 | Monoklonale antistoffer og antigener for humane ikke-liten-celle lungekarcinomer (nsclc). |
Country Status (21)
| Country | Link |
|---|---|
| EP (2) | EP0566066A1 (no) |
| JP (3) | JPH0675514B2 (no) |
| KR (1) | KR910000903B1 (no) |
| AT (1) | ATE117089T1 (no) |
| AU (1) | AU599578B2 (no) |
| DE (1) | DE3587976T2 (no) |
| DK (1) | DK170619B1 (no) |
| ES (1) | ES8704735A1 (no) |
| FI (1) | FI85814C (no) |
| GB (1) | GB2182949B (no) |
| GR (1) | GR852622B (no) |
| HU (1) | HU208546B (no) |
| IE (1) | IE58590B1 (no) |
| IL (1) | IL76877A (no) |
| NO (1) | NO862690D0 (no) |
| NZ (1) | NZ214055A (no) |
| OA (1) | OA08354A (no) |
| PH (1) | PH24961A (no) |
| PT (1) | PT81418B (no) |
| WO (1) | WO1986002735A1 (no) |
| YU (1) | YU46386B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4708930A (en) * | 1984-11-09 | 1987-11-24 | Coulter Corporation | Monoclonal antibody to a human carcinoma tumor associated antigen |
| US4906562A (en) * | 1984-12-21 | 1990-03-06 | Oncogen | Monocolonal antibodies and antigen for human non-small cell lung carcinomas |
| JPS61258173A (ja) * | 1985-05-10 | 1986-11-15 | Akira Taniuchi | モノクロ−ナル抗体およびその製法ならびに用途 |
| AU601680B2 (en) * | 1985-05-28 | 1990-09-20 | Joseph P. Brown | Monoclonal antibodies for human non-small cell lung carcinomas |
| US5185432A (en) * | 1986-02-26 | 1993-02-09 | Oncogen | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
| JPS6319561A (ja) * | 1986-07-11 | 1988-01-27 | Kyowa Hakko Kogyo Co Ltd | 抗ヒト肺癌単クロ−ン性抗体 |
| US6004761A (en) * | 1986-11-19 | 1999-12-21 | Sanofi | Method for detecting cancer using monoclonal antibodies to new mucin epitopes |
| NZ222509A (en) * | 1986-11-19 | 1993-03-26 | Oncogen | Hybridoma cell line producing antibodies binding to tumour-associated mucin antigen |
| IL89102A0 (en) * | 1988-01-29 | 1989-08-15 | Lilly Co Eli | Vectors,compounds and methods for expression of a human adenocarcinoma antigen |
| AU632469B2 (en) * | 1988-04-04 | 1993-01-07 | Johns Hopkins University, The | A method for early detection of lung cancer |
| US5171665A (en) * | 1989-04-17 | 1992-12-15 | Oncogen | Monoclonal antibody to novel antigen associated with human tumors |
| IT1264490B (it) * | 1992-02-17 | 1996-09-24 | Uni Degli Studi G D Annunzio C | Antigene 90k associato a tumori. |
| JPH0727604U (ja) * | 1993-06-18 | 1995-05-23 | 修司 坂本 | 磁気治療具 |
| EP0695760A1 (en) * | 1994-08-05 | 1996-02-07 | F. Hoffmann-La Roche Ag | Novel tumor marker for lung cancer |
| DE202012001863U1 (de) | 2012-02-22 | 2012-03-19 | Haldex Brake Products Ab | Scheibenbremse und Sensoreinrichtung hierfür |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172124A (en) | 1978-04-28 | 1979-10-23 | The Wistar Institute | Method of producing tumor antibodies |
| US4906562A (en) * | 1984-12-21 | 1990-03-06 | Oncogen | Monocolonal antibodies and antigen for human non-small cell lung carcinomas |
| JPS61258173A (ja) * | 1985-05-10 | 1986-11-15 | Akira Taniuchi | モノクロ−ナル抗体およびその製法ならびに用途 |
| AU601680B2 (en) * | 1985-05-28 | 1990-09-20 | Joseph P. Brown | Monoclonal antibodies for human non-small cell lung carcinomas |
-
1985
- 1985-10-29 IL IL76877A patent/IL76877A/xx not_active IP Right Cessation
- 1985-10-30 EP EP19930106003 patent/EP0566066A1/en not_active Withdrawn
- 1985-10-30 WO PCT/US1985/002132 patent/WO1986002735A1/en active IP Right Grant
- 1985-10-30 DE DE3587976T patent/DE3587976T2/de not_active Expired - Fee Related
- 1985-10-30 HU HU86549A patent/HU208546B/hu not_active IP Right Cessation
- 1985-10-30 EP EP85905694A patent/EP0207090B1/en not_active Expired - Lifetime
- 1985-10-30 JP JP60505034A patent/JPH0675514B2/ja not_active Expired - Lifetime
- 1985-10-30 KR KR1019860700419A patent/KR910000903B1/ko not_active IP Right Cessation
- 1985-10-30 GB GB8616219A patent/GB2182949B/en not_active Expired
- 1985-10-30 PH PH32994A patent/PH24961A/en unknown
- 1985-10-30 AU AU50691/85A patent/AU599578B2/en not_active Ceased
- 1985-10-30 AT AT85905694T patent/ATE117089T1/de not_active IP Right Cessation
- 1985-10-31 GR GR852622A patent/GR852622B/el unknown
- 1985-10-31 ES ES548421A patent/ES8704735A1/es not_active Expired
- 1985-10-31 PT PT81418A patent/PT81418B/pt not_active IP Right Cessation
- 1985-11-01 IE IE268185A patent/IE58590B1/en not_active IP Right Cessation
- 1985-11-04 YU YU172185A patent/YU46386B/sh unknown
- 1985-11-04 NZ NZ214055A patent/NZ214055A/en unknown
-
1986
- 1986-07-02 FI FI862821A patent/FI85814C/fi not_active IP Right Cessation
- 1986-07-02 DK DK314586A patent/DK170619B1/da not_active IP Right Cessation
- 1986-07-02 OA OA58895A patent/OA08354A/xx unknown
- 1986-07-02 NO NO862690A patent/NO862690D0/no unknown
-
1994
- 1994-01-12 JP JP6001442A patent/JP2567564B2/ja not_active Expired - Lifetime
- 1994-01-12 JP JP6001441A patent/JPH0733400B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Butkowski et al. | Properties of the globular domain of type IV collagen and its relationship to the Goodpasture antigen. | |
| NO862690D0 (no) | Monoklonale antistoffer og antigener for humane ikke-liten-celle lungekarcinomer (nsclc). | |
| FI102075B1 (fi) | Menetelmä valmistaa glykosyloitu tai glykosyloimaton polypeptidi, rekombinanttinukleiinihappo ja vektorit | |
| Fullmer et al. | Bovine intestinal calcium-binding proteins: Purification and some properties | |
| Jander et al. | A collagen-like glycoprotein of the extracellular matrix is the undegraded form of type VI collagen | |
| KR960705579A (ko) | 개선된 인터페론 중합체 결합체(Improved interferon polymer conjugates) | |
| KR950704489A (ko) | 인터페론 타우 조성물 및 사용방법(interferon tau compositions and methods of use) | |
| GR861141B (en) | Particles having the immunogenic properties of the hbs antigen and an antigenic side strange to the epitopes of the antigen hbs vectors and animals cells for the production of said particles and compositions containing such particles | |
| KR860002526A (ko) | 단백질의 상호 분리 방법 | |
| Lester et al. | A postsynthetic modification of human α-fetoprotein controls its immunosuppressive potency | |
| Stathakis et al. | Human fibrinogen heterogeneities. Preparation and characterization of γ and γ′ chains | |
| Novak-Hofer et al. | Two-dimensional separation of chloroplast membrane proteins by isoelectri focusing and electrophoresis in sodium dodecyl sulphate | |
| GR3007909T3 (no) | ||
| Beesley et al. | Glycoproteins and glycolipids of oxyntic cell microsomes I. Glycoproteins: Carbohydrate composition, analytical and preparative fractionation | |
| Canicattì et al. | Studies on Holothuriapolii (echinodermata) coelomocyte lysate II. Isolation of coelomocyte hemolysins | |
| DE69529750D1 (de) | Verbesserungen in der herstellung von proteinen in wirtszellen | |
| Obinata et al. | The subunit structure of myosin from skeletal muscle of the early chick embryo | |
| Shelley et al. | Immunologically related multimeric forms of 30–40 kDa peptides associated with lung surfactant in various mammalian species | |
| Asakawa et al. | Origin of human triosephosphate isomerase isozymes: further evidence for the single structural locus hypothesis with Japanese variants | |
| Alekseeva et al. | Chemical fragmentation by o-iodosobenzoic acid of alpha-chain of histidine decarboxylase from Micrococcus sp. n. AT tryptophan residues. | |
| Schalekamp et al. | Recombination of embryonic haemoglobin chains during the development of the chick | |
| Mohr et al. | Antibodies to interleukin-2 (IL-2) in patients: cross reactivity with different IL-2 species | |
| Strnad et al. | Biochemical characterization of Epstein-Barr virus membrane antigen associated glycoproteins | |
| Trüeb et al. | Type IV collagen is a heteropolymer with the formula C2D | |
| Fehlmann et al. | Free and membrane-bound rabbit reticulocyte ribosomes. Proteins from the large and the small subunits |